- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ATG-010 60 mg, orally, twice weekly, each 4 week (28-day) a cycle
Total 9 results
-
Antengene CorporationActive, not recruitingRelapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)China
-
Shanghai Antengene Corporation LimitedTerminatedAdvanced Solid TumorsChina
-
Federal Budgetary Research Institution State Research...CompletedSmallpox | Monkeypox | Cowpox | Vaccinia Virus InfectionRussian Federation
-
Royal Marsden NHS Foundation TrustHoffmann-La Roche; Professor Cunningham's Clinical Research FundCompletedPancreatic CancerUnited Kingdom
-
Fox Chase Cancer CenterWithdrawnNon-Small Cell Lung CancerUnited States
-
Jiuda ZhaoSecond Hospital of Lanzhou UniversityRecruiting
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
Memorial Sloan Kettering Cancer CenterBoehringer Ingelheim; National Comprehensive Cancer NetworkCompletedHead and Neck Cancer | Squamous Cell CancerUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States